63089-56-5 Usage
Description
1,2,3,5,6,7-Hexahydro-s-indacen-4-amine is a white solid that serves as a valuable synthetic intermediate in the chemical industry. Its unique molecular structure allows for various applications in different fields, making it a versatile compound for chemical synthesis.
Uses
1. Used in Pharmaceutical Industry:
1,2,3,5,6,7-Hexahydro-s-indacen-4-amine is used as a synthetic intermediate for the development of new pharmaceutical compounds. Its structural properties enable the creation of novel drugs with potential therapeutic applications.
2. Used in Chemical Synthesis:
1,2,3,5,6,7-Hexahydro-s-indacen-4-amine is used as a building block in the synthesis of various organic compounds. Its reactivity and compatibility with other chemical groups make it a suitable candidate for creating a wide range of molecules with diverse properties and applications.
3. Used in Research and Development:
1,2,3,5,6,7-Hexahydro-s-indacen-4-amine is utilized in research and development laboratories for the exploration of new chemical reactions and the synthesis of innovative molecules. Its unique properties provide researchers with a valuable tool for advancing scientific knowledge and discovering new applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 63089-56-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,0,8 and 9 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 63089-56:
(7*6)+(6*3)+(5*0)+(4*8)+(3*9)+(2*5)+(1*6)=135
135 % 10 = 5
So 63089-56-5 is a valid CAS Registry Number.
63089-56-5Relevant articles and documents
-
Birladeanu,L. et al.
, p. 3260 - 3264 (1977)
-
NLRP MODULATORS
-
, (2020/01/31)
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein, useful to treat connected to the modulation of NRLP3.
SULFONIMIDAMIDE COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
-
, (2020/08/13)
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: (Formula AA) or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.
